Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study - Giovannoni, G; Sorensen, PS; Cook, S; Rammohan, K; Rieckmann, P; Comi, G (Mult Scler, 2018)